(Q42996974)

English

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots

scientific article published in April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Matthew Hickman

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

S L Ngui

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

S Jones

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Telfer

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Bizzarri

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

F Ncube

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

J V Parry

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

262-270

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Transmission of hepatitis C virus: rates, routes, and cofactors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Implementation and analysis of respondent driven sampling: lessons learned from the field

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

High hepatitis C incidence in new injecting drug users: a policy failure?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

A method to detect the incidence of hepatitis C infection among injecting drug users in Glasgow 1993-98.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Failure to diagnose recent hepatitis C virus infections in London injecting drug users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Treatment of acute hepatitis C with interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Respondent-Driven Sampling II: Deriving Valid Population Estimates from Chain-Referral Samples of Hidden Populations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

5. Sampling and Estimation in Hidden Populations Using Respondent-Driven Sampling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01297.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2010.01297.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42996974&oldid=1976299266"